EN

Translate:

ATTEND OUR ACADEMIC WEBINARS

ENTOD INTERNATIONAL
ENTOD INTERNATIONAL
  • Home
  • About Us
  • Products
  • ENTOMEET ONLINE
  • Feedback
  • News
  • Patient Centre
  • Professional Support
  • Contact Us
  • More
    • Home
    • About Us
    • Products
    • ENTOMEET ONLINE
    • Feedback
    • News
    • Patient Centre
    • Professional Support
    • Contact Us
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out


EN

Signed in as:

filler@godaddy.com

  • Home
  • About Us
  • Products
  • ENTOMEET ONLINE
  • Feedback
  • News
  • Patient Centre
  • Professional Support
  • Contact Us

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

FORMULATION TECHNOLOGIES

Our research teams are constantly involved in the development of innovative drug delivery systems in ophthalmic & ENT therapeutics, that can be incorporated into our finished products. This gives our products the technological edge & improves treatment outcomes. 


Our FDA approved international formulation R&D facilities provide us with the technologies to develop and design the highest quality formulations and continuously innovate in various areas of pharmaceuticals. Our research teams consist of some of the most experienced pharmaceutical scientists & chemists engaging in new product development, formulation optimization and clinical trials. Our formulations therefore have the technological edge compared to the more traditional therapies available. 



THE OXYDEW™Buffer System for Dry Eye Therapies

OXYDEW™ – The Innovative Buffer System for use with Dry Eye Therapies

This advanced borate-based buffer provides better comfort, longer-lasting ocular lubrication and greater formulation stability. 

SEDDS™ – The New Drug Delivery System for Eye Drops

SEDDS™ – The New Drug Delivery System for Eye Drops 


ENTOD's CYCLOTEARS™ Eye Drops contains 0.05% Cyclosporin and is formulated with the ground-breaking SEDDS™ vehicle. 

NOVELIA® Preservative-FREE Eye Drop Technology.

NOVELIA® Preservative-FREE Eye Drop Technology. 


ENTOD has tied up with the French pharmaceutical technology giant NEMERA (France) to develop and launch Preservative-FREE Multi-dose eye drops 

4GOS™ Fourth Generation Suspension Technology.

4GOS™ Fourth Generation Ocular Suspension Technology. 


ENTOD's research team has developed an innovative micronized ocular suspension that gives better formulation stability, greater bioavailability, more accurate dosing and reduced ocular irritation. This technology can be incorporated into eye drop formulations containing insoluble ocular molecules

Phenocaine Plus ® INTRACAMERAL MYDRIATIC

PHENOCAINE PLUS ® INTRACAMERAL INJECTION 


A preservative-free & terminally sterilized intracameral injection containing Phenylephrine, Lidocaine & Tropicamide. Phenocaine Plus is injected during cataract surgery to achieve rapid and stable pupillary dilatation without the use of preoperative dilating eye drops and sustained intraocular anaesthesia for pain-free surgery and better surgical outcomes.

SeE THE ENTOD INNOVATION VIDEO

see our youtube channel for more videos

Click here

Copyright © 2023 ENTOD INTERNATIONAL - All Rights Reserved.

  • About Us
  • Products
  • News
  • Formulation Technologies
  • Speciality Excipients
  • Privacy Policy
  • Contact Us

Cookie Policy

This website uses cookies. By continuing to use this site, you accept our use of cookies.

DeclineAccept & Close